Dr. Geynisman Discusses Immunotherapy in RCC – OncLive
|
Dr. Geynisman Discusses Immunotherapy in RCC
OncLive Daniel M. Geynisman, MD, assistant professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses immunotherapy in metastatic renal cell carcinoma (mRCC). Patients are excited and willing to participate in clinical trials of … |
